Gupta, S., Waller, E., Reshef, R., Vanguru, V., Olszewski, A., Solomon, S., Maakaron, J., Raval, A., Yavrom, S., Byon, J., Shah, B. (2025). Azer-cel, an allogeneic (allo) CD19 CAR T, in combination with low-dose interleukin-2 (IL-2) demonstrates clinical activity in patients with large B-cell lymphoma (LBCL) who relapsed after autologous (auto) CAR T. Blood. https://doi.org/10.1182/blood-2025-267